PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS

PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS

Bibliographic Details
Main Authors:	Rajshekhar Chakraborty, Claudia Bellofiore, Marco Basset, Mario Nuvolone, Andrea Foli, Giampaolo Merlini, Giovanni Palladini, Mathew Maurer, Markus Mapara, Divaya Bhutani, Suzanne Lentzsch, Paolo Milani
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975364.74026.0a

Similar Items

Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
by: Rajshekhar Chakraborty, et al.
Published: (2023-11-01)

LIGHT CHAIN AMYLOIDOSIS
by: Paolo Milani, et al.
Published: (2018-03-01)

Predicting survival in light chain amyloidosis
by: Giovanni Palladini, et al.
Published: (2019-07-01)

A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis
by: Giovanni Palladini, et al.
Published: (2013-03-01)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
by: Giovanni Palladini, et al.
Published: (2021-03-01)

Current treatment of AL amyloidosis
by: Giovanni Palladini, et al.
Published: (2009-08-01)

Light chain amyloidosis: the heart of the problem
by: Giampaolo Merlini, et al.
Published: (2013-10-01)

Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach
by: Giovanni Palladini, et al.
Published: (2014-04-01)

Bortezomib in the treatment of AL amyloidosis: targeted therapy?
by: Roberto Sitia, et al.
Published: (2007-10-01)

Predictors of Early Death in Patients With Wild‐Type Transthyretin Cardiac Amyloidosis
by: Paolo Milani, et al.
Published: (2025-01-01)

Treating advanced cardiac damage in light chain amyloidosis: still an unmet need
by: Giampaolo Merlini, et al.
Published: (2014-09-01)

AL AMYLOIDOSIS: MECHANISMS OF DISEASE AND BIOMARKERS
by: Giovanni Palladini, et al.
Published: (2022-04-01)

AA amyloidosis: basic knowledge, unmet needs and future treatments
by: Laura Obici, et al.
Published: (2012-05-01)

Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis
by: Hughes MS, et al.
Published: (2023-12-01)

Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis
by: Tim Schulte, et al.
Published: (2024-07-01)

Therapy and management of systemic AL (primary) amyloidosis
by: G Palladini, et al.
Published: (2006-11-01)

Update on treatment of light chain amyloidosis
by: Shameem Mahmood, et al.
Published: (2014-02-01)

Lung Transplantation for Pulmonary AL Amyloidosis
by: Matthew I. Ehrlich, MD, et al.
Published: (2024-03-01)

Amyloid and amyloidosis /
by: Skinner, Martha, et al.
Published: (2005)

Cardiac amyloidosis
by: Natallia Laptseva, et al.
Published: (2024-11-01)

Tracheal amyloidosis
by: Ruwan Amaratunga, et al.
Published: (2014-01-01)

Tracheobronchial amyloidosis
by: Khalil Jivraj, et al.
Published: (2014-01-01)

Cardiac amyloidosis
by: Magdalena Balwierz, et al.
Published: (2024-06-01)

Cardiac Amyloidosis
by: Michelle M. Kittleson, MD, PhD
Published: (2024-08-01)

Cardiac amyloidosis
by: Gnana Deepthi Medarametla, et al.
Published: (2023-08-01)

Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma
by: George Mellgard, et al.
Published: (2024-03-01)

Bone Marrow Microenvironment in Light-Chain Amyloidosis: In Vitro Expansion and Characterization of Mesenchymal Stromal Cells
by: Chiara Valsecchi, et al.
Published: (2021-10-01)

PB2008: CUTANEOUS HEMORRHAGIC SYNDROME IN PATIENTS WITH AL-AMYLOIDOSIS
by: V. Khyshova, et al.
Published: (2022-06-01)

P823: BONE MARROW-FREE SEQUENCING OF M PROTEIN GENES IN MONOCLONAL GAMMOPATHIES
by: Alice Nevone, et al.
Published: (2023-08-01)

Management of transthyretin amyloidosis
by: Adalgisa Condoluci, et al.
Published: (2021-10-01)

Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis
by: Rahel Schwotzer, et al.
Published: (2020-12-01)

A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic Datasets
by: Alice Nevone, et al.
Published: (2023-04-01)

Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis)
by: Mari Kantanen, et al.
Published: (2014-07-01)

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts
by: Iman Meziane, et al.
Published: (2017-10-01)

PB2155: B-CELL NON-HODGKIN’S LYMPHOMAS ASSOCIATED WITH AMYLOIDOSIS
by: M. Navrátilova, et al.
Published: (2022-06-01)

PB2135: TREATMENT PATTERNS IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
by: Anita D’souza, et al.
Published: (2023-08-01)

Amyloidosis and the Syncopal Enigma
by: Brittany Strelow, et al.
Published: (2024-12-01)

AMYLOIDOSIS HEART IN ELDERLY
by: L. I. Dvoretsky, et al.
Published: (2015-12-01)

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)

Catastrophic Cardiac Amyloidosis
by: Prashanth Panduranga, et al.
Published: (2011-01-01)